New AAM CEO Looking To ‘Force Multiply’ For US Generics Industry

 
• By Derrick Gingery
  
leadership
John Murphy, formerly of BIO, will take over as AAM CEO. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Interviews